Haznedaroğlu IC - Search Results

1

A local renin-angiotensin system in the bone marrow.

Haznedaroğlu IC, Tuncer S, Gürsoy M. Haznedaroğlu IC, et al. Med Hypotheses. 1996 Jun;46(6):507-10. doi: 10.1016/s0306-9877(96)90122-x. Med Hypotheses. 1996. PMID: 8803932

2

Enhanced expression of the local haematopoietic bone marrow renin-angiotensin system in polycythemia rubra vera.

Aksu S, Beyazit Y, Haznedaroglu IC, Kekilli M, Canpinar H, Misirlioğlu M, Uner A, Tuncer S, Sayinalp N, Büyükaşik Y, Goker H, Ozcebe OI. Aksu S, et al. Among authors: haznedaroglu ic. J Int Med Res. 2005 Nov-Dec;33(6):661-7. doi: 10.1177/147323000503300608. J Int Med Res. 2005. PMID: 16372584 Free article.

3

A unifying hypothesis for the renin-angiotensin system and hematopoiesis: sticking the pieces together with the JAK-STAT pathway.

Haznedaroğlu IC, Arici M, Büyükaşik Y. Haznedaroğlu IC, et al. Med Hypotheses. 2000 Jan;54(1):80-3. doi: 10.1054/mehy.1998.0830. Med Hypotheses. 2000. PMID: 10790731

4

Agranulocytosis, plasmacytosis, and thrombocytosis followed by a leukemoid reaction due to acute acetaminophen toxicity.

Gürsoy M, Haznedaroğlu IC, Celik I, Sayinalp N, Ozcebe OI, Dündar SV. Gürsoy M, et al. Among authors: haznedaroglu ic. Ann Pharmacother. 1996 Jul-Aug;30(7-8):762-5. doi: 10.1177/106002809603000710. Ann Pharmacother. 1996. PMID: 8826556

5

Local bone marrow renin-angiotensin system in the genesis of leukemia and other malignancies.

Haznedaroglu IC, Malkan UY. Haznedaroglu IC, et al. Eur Rev Med Pharmacol Sci. 2016 Oct;20(19):4089-4111. Eur Rev Med Pharmacol Sci. 2016. PMID: 27775788 Free article. Review.

6

Effects of imatinib mesylate on renin-angiotensin system (RAS) activity during the clinical course of chronic myeloid leukaemia.

Sayitoglu M, Haznedaroğlu IC, Hatirnaz O, Erbilgin Y, Aksu S, Koca E, Adiguzel C, Bayik M, Akalin I, Gülbas Z, Akay M, Unal A, Kaynar L, Ovali E, Yilmaz M, Yenerel M, Dagdas S, Ozet G, Ar C, Aydin Y, Soysal T, Durgun B, Ozcebe O, Tukun A, Ilhan O, Ozbek U. Sayitoglu M, et al. Among authors: haznedaroglu ic. J Int Med Res. 2009 Jul-Aug;37(4):1018-28. doi: 10.1177/147323000903700406. J Int Med Res. 2009. PMID: 19761684 Free article. Clinical Trial.

7

Effect of recombinant human erythropoietin on soluble interleukin 2 receptor (SIL-2R) levels in haemodialysis patients.

Altun B, Erdem Y, Haznedaroğlu I, Gürsoy M, Yasavul U, Turgan C, Cağlar S, Kirazli S. Altun B, et al. Nephrol Dial Transplant. 1995 Nov;10(11):2164. Nephrol Dial Transplant. 1995. PMID: 8643199 No abstract available.

8

Plasma basic fibroblast growth factor and bone marrow fibrosis in clonal myeloproliferative disorders.

Sayinalp N, Cinar H, Uner A, Haznedaroğlu IC, Büyükaşik Y, Göker H, Aksu S, Ozcebe OI, Karakuş S, Kirazli S, Dündar SV. Sayinalp N, et al. Among authors: haznedaroglu ic. Clin Lab Haematol. 2004 Aug;26(4):265-8. doi: 10.1111/j.1365-2257.2004.00616.x. Clin Lab Haematol. 2004. PMID: 15279663 Clinical Trial.

9

Effects of angiotensin converting enzyme and angiotensin II receptor inhibition on impaired fibrinolysis in systemic hypertension.

Erdem Y, Usalan C, Haznedaroğlu IC, Altun B, Arici M, Yasavul U, Turgan C, Cağlar S. Erdem Y, et al. Among authors: haznedaroglu ic. Am J Hypertens. 1999 Nov;12(11 Pt 1):1071-6. doi: 10.1016/s0895-7061(99)00145-4. Am J Hypertens. 1999. PMID: 10604482 Clinical Trial.

10

Renin-like activity in leukemic blast cells: an initial clue to a local renin-angiotensin system in the bone marrow.

Haznedaroğlu IC, Savaş MC, Benekli M. Haznedaroğlu IC, et al. Ann Hematol. 1997 Jul-Aug;75(1-2):69-70. doi: 10.1007/s002770050316. Ann Hematol. 1997. PMID: 9322688 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

377 results

Search Page